| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/CNCR.22636 |
| P698 | PubMed publication ID | 17407138 |
| P2093 | author name string | Akihiko Okuyama | |
| Yoshitaka Isaka | |||
| Ryoichi Imamura | |||
| Norio Nonomura | |||
| Shiro Takahara | |||
| Masayoshi Okumi | |||
| Tetsuya Imao | |||
| Naotsugu Ichimaru | |||
| Yukiomi Namba | |||
| Yukito Kokado | |||
| P2860 | cites work | Tacrolimus versus ciclosporin as primary immunosuppression for kidney transplant recipients: meta-analysis and meta-regression of randomised trial data | Q31004418 |
| Cancer in patients on dialysis for end-stage renal disease: an international collaborative study | Q33845510 | ||
| Malignancies in organ transplant recipients | Q35885193 | ||
| N-terminal fragments of the proatrial natriuretic peptide in plasma and urine of kidney graft recipients | Q43685027 | ||
| Cancer risk after renal transplantation in Japan | Q43816870 | ||
| Influence of immunosuppression on the prevalence of cancer after kidney transplantation | Q44503104 | ||
| Immunosuppression and the risk of post-transplant malignancy among cadaveric first kidney transplant recipients | Q44695050 | ||
| Low incidence of malignancy among sirolimus/cyclosporine-treated renal transplant recipients | Q46740550 | ||
| Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression | Q46825318 | ||
| Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. | Q47206753 | ||
| Tacrolimus (FK 506) in kidney transplantation: three-year survival results of the US multicenter, randomized, comparative trial. FK 506 Kidney Transplant Study Group | Q47940130 | ||
| Risk of neoplasia in renal transplant patients. | Q52870351 | ||
| Risk of malignancy with long-term immunosuppression in renal transplant recipients. | Q53288353 | ||
| Cancer risk after renal transplantation in the nordic countries, 1964-1986 | Q58411715 | ||
| Prevalence of co-morbidity in different European RRT populations and its effect on access to renal transplantation | Q59361785 | ||
| Lymphomas after solid organ transplantation: a collaborative transplant study report | Q76376056 | ||
| Does cyclosporin A cause cancer? | Q77966107 | ||
| Cancer after kidney transplantation in the United States | Q80096845 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 2109-2115 | |
| P577 | publication date | 2007-05-01 | |
| P1433 | published in | Cancer | Q326041 |
| P1476 | title | Risk factors for malignancy in Japanese renal transplant recipients | |
| P478 | volume | 109 |
| Q36022600 | Cancer Incidence among Heart, Kidney, and Liver Transplant Recipients in Taiwan |
| Q33888107 | Cancer in Korean patients with end-stage renal disease: A 7-year follow-up |
| Q57225071 | Clinical significance of gastric cancer surveillance in renal transplant recipients |
| Q93136713 | Effect of Converting From Calcineurin Inhibitor- to Sirolimus-Based Immunosuppressant Regimen on Breast Fibroadenoma Among Kidney Transplant Patients |
| Q47815610 | Gene Expression Profiling of Peripheral Blood From Kidney Transplant Recipients for the Early Detection of Digestive System Cancer |
| Q92367894 | Head and neck cancer in living donor liver transplant recipients: Single center retrospective study |
| Q24243208 | Immunosuppressive agents for myasthenia gravis |
| Q35150650 | Incidence and clinicopathologic behavior of uterine cervical carcinoma in renal transplant recipients |
| Q42478812 | Incidence and risk factors for nonmelanoma skin cancer after heart transplantation. |
| Q36072514 | Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control. |
| Q37305391 | Japan's experience with living-donor kidney transplantation across ABO barriers |
| Q37206083 | Lessons Learned From a Case of Gastric Cancer After Liver Transplantation for Hepatocellular Carcinoma: A Case Report and Literatures Review |
| Q33834315 | Long-term cancer risk of immunosuppressive regimens after kidney transplantation |
| Q40496068 | Malignancies after living-donor and cadaveric lung transplantations in Japanese patients |
| Q91996365 | Malignancy With Immunosuppression After Renal Transplantation: A Competing Risk Analysis |
| Q36225611 | Multiple Skin Cancers in a Renal Transplant Recipient: A Patient Report with Analyses of Human Papillomavirus and Human Polyomavirus Infection |
| Q49588376 | National survey of de novo malignancy after solid organ transplantation in Japan |
| Q57750146 | Polygenic risk score as a determinant of risk of non-melanoma skin cancer in a European-descent renal transplant cohort |
| Q40633383 | Renal Tumor in Allogeneic Kidney Transplant Recipient |
| Q37522597 | Tacrolimus confers lower acute rejection rates and better renal allograft survival compared to cyclosporine |
| Q36528417 | The benefits of cancer screening in kidney transplant recipients: a single-center experience |
| Q42182928 | The efficacy of EBER in situ hybridization (ISH) stain in PTLD (malignant diffuse large B-cell lymphoma) about 4 years after ABO-incompatible kidney transplantation: a case report |
| Q42507636 | The incidence of post-transplant cancer among kidney transplant recipients is associated with the level of tacrolimus exposure during the first year after transplantation |
Search more.